Ahead of its investor day today, McKesson (MCK) reaffirms its FY 2014 adjusted EPS guidance of...

|About: McKesson Corporation (MCK)|By:, SA News Editor

Ahead of its investor day today, McKesson (MCK) reaffirms its FY 2014 adjusted EPS guidance of $7.90-$8.20 and the key underlying assumptions behind the forecast. These include a significant rebound in Distribution Solutions revenue growth and drug prices similar to 2013. Analysts expect EPS of $8.07.